Home Premarket Biotech Digest: Gilead's Upside, Shire-Baxalta Deal, ARIAD Lowers Guidance
 

Keywords :   


Premarket Biotech Digest: Gilead's Upside, Shire-Baxalta Deal, ARIAD Lowers Guidance

2015-12-14 14:57:58| Biotech - Topix.net

I will be looking at some of the big names in the biotech sector over the next two weeks, starting with Gilead Sciences today. Within the large cap growth space in the biotech sector , Gilead continues to be my top pick.

Tags: deal guidance digest biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
15.11 Next%
15.112019 figma
15.11[] 5
15.11!!
15.11S11 NITRO 156cm
15.1115
15.1127.2mm
15.11 35
More »